Carvedilol Tablet, Film Coated
Product Images NDC 70518-1377

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 70518-1377). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carvedilol 3.125mg 70518 1377 03

Label for Carvedilol 3.125 mg film-coated tablets, quantity 100. The label includes the NDC number 70518-1377-03, repackaged by RemedyRepack Inc. It states the manufacturer as Zydus Pharm, Pennington, NJ. Storage instructions note 20-25°C with permitted excursions and directions refer to the package insert.*

FDA Label Image

Carvedilol 3.125mg 70518 1377 04

Carvedilol 3.125 mg film-coated tablet packaging label showing quantity of 1 tablet. The label includes manufacturing information from Zydus Pharm, Pennington, NJ, and is repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions specify 20-25°C with permitted excursions to 15-30°C. The label features a barcode and a QR code.*

FDA Label Image

Remedy Label

Carvedilol 3.125 mg film coated tablets packaging label from RemedyRepack Inc. The label indicates a quantity of 30 tablets and includes regulatory information such as NDC 70518-1377-00 and repackaging details. Manufacturer information lists Zydus Pharm, Pennington, NJ.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Chemical structure diagram of Carvedilol showing its molecular connectivity including multiple rings and functional groups relevant to the compound's composition.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

A Kaplan-Meier survival curve comparing mortality percentages over a 21-month period between placebo and carvedilol treatment groups. The y-axis shows percent mortality, increasing up to 30%, and the x-axis shows time in months. The carvedilol group consistently has lower mortality compared to the placebo group, with a statistically significant difference (p = 0.0014).*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

A forest plot displaying hazard ratios across various patient subgroups, including sex, age, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use. Each subgroup is represented by a point estimate with confidence intervals along a horizontal axis ranging from 0 to 2, centered around a reference line at 1.0.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

A line graph comparing the percentage mortality over 24 months between Carvedilol and a placebo. The x-axis represents months, and the y-axis shows percentage mortality. The Carvedilol group demonstrates a lower mortality rate than the placebo group, with a reported statistical significance of P = 0.03.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

A forest plot chart depicting hazard ratios for various subgroups such as age, gender, prior heart conditions, and clinical characteristics. The chart visually compares different patient groups and treatment effects, with hazard ratios plotted along a horizontal axis ranging approximately from 0.4 to 1.3.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.